- Tularemia, also known as rabbit fever, is a rare infectious disease caused by the bacterium Francisella tularensis. It can be transmitted through insect bites, exposure to infected animals, or inhalation of contaminated particles. The disease can be fatal if not treated promptly, but it responds well to antibiotics.
- The market is witnessing growth due to initiatives for epidemic preparedness, increased public health funding, and robust research into vaccine development.
- North America dominates the Tularemia market due to strong surveillance systems, increased funding for rare disease research, and active government biodefense programs. The U.S. in particular is a major contributor due to CDC’s inclusion of tularemia as a category A bioterrorism agent.
- Asia-Pacific is expected to be the fastest growing region, driven by expanding public health programs, increased zoonotic surveillance, and research investments in emerging economies like India and China.
- In 2025, the ulceroglandular type is expected to dominate the market with a share of 41.6%, due to its higher prevalence and ease of clinical diagnosis compared to other forms
